{
    "data": [
        {
            "id": "69038597ecb8a700014597c7",
            "title": "Chip Stocks Just Flashed The Same Signal That Flagged A 30% Crash Last Year",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">The semiconductor rally has gone from hot to overheated. Chip-stocks-tracking VanEck Semiconductor ETF (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/SMH\" target=\"_blank\">SMH</a>) is now stretched far above its 200-day moving average — the widest gap since July 2024, right before <a href=\"https://www.benzinga.com/topic/semiconductors\" target=\"_blank\">chip stocks cratered</a> 30% in a matter of weeks.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Track SMH ETF <a href=\"https://www.benzinga.com/quote/SMH\" target=\"_blank\">here</a>.</strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><em><a href=\"https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent103025&amp;t=be2bearmibe3na1\" target=\"_blank\">Chart created using Benzinga Pro</a></em></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Deja Vu For AI Bulls</h2><!--/$--><!--$--><p class=\"block core-block\">Back then, the euphoria was also AI-fueled — <strong>Nvidia Corp</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>) was breaking records, and every chipmaker was suddenly a \"picks-and-shovels\" play on artificial intelligence. The parallels are striking: valuations are frothy, momentum is euphoric, and traders are ignoring how stretched the charts have become.</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">Since early October, SMH has surged more than 20%, outpacing the broader market by a wide margin. But this kind of vertical move rarely ends quietly — the technical setup now looks eerily similar to the July 2024 peak that preceded a brutal correction, <a href=\"https://x.com/Barchart/status/1983284176301211758?s=31\" target=\"_blank\">noted</a> Barchart.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/markets/tech/25/10/48460388/nvidia-amd-broadcoms-combined-value-surges-1000-in-just-three-years-and-bulls-want-more\" target=\"_blank\">AMD, Nvidia, Broadcom’s Combined Value Surges 1000% In Just Three Years — And Bulls Want More</a></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Fundamentals Still Strong, But…</h2><!--/$--><!--$--><p class=\"block core-block\">This isn't 2022's semiconductor slump. Nvidia, <strong>Advanced Micro Devices Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMD\" target=\"_blank\">AMD</a>), and <strong>Broadcom Inc </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AVGO\" target=\"_blank\">AVGO</a>) are still posting robust AI-driven demand, and chip shortages in networking and data centers remain a tailwind. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The problem isn't fundamentals — it's sentiment. When everything looks priced for perfection, even a slight wobble in AI demand or CapEx spending can spark outsized pain.</p><!--/$--><!--$--><p class=\"block core-block\">Technical analysts now warn that SMH's relative strength index (RSI) is flashing overbought signals at 69.43, and prior peaks at these levels have historically triggered swift 10–20% retracements.</p><!--/$--><!--$--><p class=\"block core-block\">Semiconductor bulls have every reason to stay optimistic long term — AI's infrastructure buildout is still in early innings. But near-term, the trade looks stretched. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Last time chip stocks flew this high above their 200-day line, gravity struck fast and hard. Investors betting on a \"new normal\" might want to remember: momentum burns brightest right before it goes dark.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48533349\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/etfs/sector-etfs/25/10/48410030/intel-earnings-jolt-adds-new-life-to-semiconductor-etfs-3-funds-to-watch\" target=\"_blank\">Intel’s Earnings Jolt Adds New Life To Semiconductor ETFs: 3 Funds To Watch</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/AI.jpeg",
            "link": "https://www.benzinga.com/markets/tech/25/10/48533349/chip-stocks-just-flashed-the-same-signal-that-flagged-a-30-crash-last-year",
            "pub_date": "2025-10-30 23:34:50",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690386b2ecb8a70001459871",
            "title": "Pfizer Blasts Novo Nordisk&#39;s $9 Billion Counteroffer For Metsera As &#39;Reckless&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Thursday, <strong>Metsera Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MTSR\" target=\"_blank\">MTSR</a>) received an <a href=\"https://www.benzinga.com/topic/mergers-and-acquisitions\" target=\"_blank\">unsolicited acquisition proposal </a>from <strong>Novo Nordisk A/S</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVO\" target=\"_blank\">NVO</a>).</p><!--/$--><!--$--><p class=\"block core-block\">Metsera said the proposal constitutes a “Superior Company Proposal” as defined in Metsera’s existing Merger Agreement with <strong>Pfizer Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PFE\" target=\"_blank\">PFE</a>).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">In September, Pfizer agreed to acquire Metsera for $47.50 per share in cash, representing an enterprise value of <a href=\"https://www.benzinga.com/m-a/25/09/47787042/pfizer-tries-to-revitalize-obesity-portfolio-with-5-billion-matsera-deal\" rel=\"noreferrer noopener\" target=\"_blank\">approximately $4.9 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The acquisition brings a portfolio of differentiated oral and injectable incretin, non-incretin, and combination therapy candidates.</p><!--/$--><!--$--><p class=\"block core-block\">Novo Nordisk’s proposal is structured in two steps.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>In the first step, immediately following the signing of a definitive agreement, Novo Nordisk would pay <a href=\"https://www.benzinga.com/pressreleases/25/10/n48522694/metsera-receives-unsolicited-proposal-from-novo-nordisk\" rel=\"noreferrer noopener\" target=\"_blank\">Metsera $56.50 per share</a> in cash, as well as certain amounts related to Metsera employee equity and transaction expenses.</li>\n<li>In exchange, Metsera would issue Novo Nordisk non-voting preferred stock representing 50% of Metsera’s share capital.</li>\n<li>On the same day, Metsera would declare a dividend of $56.50 per Metsera common share, payable in cash, to be distributed 10 days later.</li>\n</ul><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">In the second step, which would happen only after receiving approval from Metsera shareholders and relevant regulators, Metsera shareholders would receive a contingent value right representing up to $21.25 per share in cash based on development and regulatory approval milestones.</p><!--/$--><!--$--><p class=\"block core-block\">This proposal values Metsera at up to $77.75 per share, for approximately $9 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer, in a press release on Thursday, stated that it is aware of Novo Nordisk’s proposal, which it considers<a href=\"https://www.benzinga.com/pressreleases/25/10/b48522228/pfizer-addresses-proposal-for-metsera\" target=\"_blank\"> “reckless and unprecedented.”</a></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Pfizer stated that it is an attempt by a company with a dominant market position to suppress competition in violation of the law by acquiring an emerging American challenger.</p><!--/$--><!--$--><p class=\"block core-block\">It is also structured in a way that circumvents antitrust laws and carries substantial regulatory and operational risks.</p><!--/$--><!--$--><p class=\"block core-block\">The proposal is illusory and cannot qualify as a superior proposal under Pfizer’s agreement with Metsera.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer is prepared to pursue all legal avenues to enforce its rights under the agreement.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">As disclosed in Metsera’s proxy, the Board of Metsera previously rejected Novo Nordisk’s proposal due to “a variety of risks” in its deal structure. The Board chose Pfizer over other bidders because none “could complete an acquisition of 100% of Metsera’s equity with the same level of certainty or on the same expected timeline as Pfizer.”</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: MTSR stock is up 21.03% at $63.19, and NVO stock is down 2.31% at $50.19 at the last check on Thursday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/earnings/25/10/48519623/alphabets-ai-bet-delivers-record-100-billion-quarter-cloud-backlog-surges-to-155-billion\" rel=\"noreferrer noopener\" target=\"_blank\">Alphabet’s AI Bet Delivers Record $100 Billion Quarter, Cloud Backlog Surges To $155 Billion</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: jittawit21/Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48533502\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Genetic-Research-And-Biotech-Science-Con.jpeg",
            "link": "https://www.benzinga.com/m-a/25/10/48533502/pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless",
            "pub_date": "2025-10-30 23:39:34",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69037749ecb8a70001458d86",
            "title": "Coinbase Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Coinbase Global, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/COIN\" target=\"_blank\">COIN</a>) will release earnings results for the third quarter, after the <a href=\"https://www.benzinga.com/quote/coin/earnings\" target=\"_blank\">closing bell on Thursday, Oct. 30.</a></p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect the New York-based company to report quarterly earnings at $1.1 per share, up from 28 cents per share in the year-ago period. The consensus estimate for Coinbase's quarterly revenue is $1.8 billion, compared to $1.21 billion a year earlier, according to data from <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company missed analyst estimates for revenue in two straight quarters, but beat estimates in seven of the past 10 quarters overall.</p><!--/$--><!--$--><p class=\"block core-block\">Coinbase shares fell 1.9% to close at $348.61 on Wednesday.</p><!--/$--><!--$--><p class=\"block core-block\">Benzinga readers can access the latest analyst ratings on the <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie\" target=\"_blank\">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p><!--/$--><!--$--><p class=\"block core-block\">Let's have a look at how Benzinga's most-accurate <a href=\"https://www.benzinga.com/quote/coin/analyst-ratings\" target=\"_blank\">analysts have rated the company</a> in the recent period.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Rosenblatt analyst Chris Brendler maintained a Buy rating and cut the price target from $470 to $450 on Oct. 29, 2025. This analyst has an accuracy rate of 80%.</li>\n<li>Barclays analyst Benjamin Budish maintained an Equal-Weight rating and cut the price target from $365 to $361 on Oct. 8, 2025. This analyst has an accuracy rate of 76%.</li>\n<li>Canaccord Genuity analyst Joseph Vafi maintained a Buy rating with a price target of $400 on Aug. 1, 2025. This analyst has an accuracy rate of 80%.</li>\n<li>Needham analyst Jon Todaro maintained a Buy rating and raised the price target from $270 to $400 on Aug. 1, 2025. This analyst has an accuracy rate of 90%.</li>\n<li>HC Wainwright &amp; Co. analyst Mike Colonnese reiterated a Sell rating with a price target of $300 on Aug. 1, 2025. This analyst has an accuracy rate of 80%.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Considering buying COIN stock? Here’s what analysts think: </p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>Read This Next:<a href=\"https://www.benzinga.com/trading-ideas/short-ideas/25/10/48489767/top-2-energy-stocks-that-may-implode-this-quarter-2\" target=\"_blank\"> </a></strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/trading-ideas/short-ideas/25/10/48489767/top-2-energy-stocks-that-may-implode-this-quarter-2\" target=\"_blank\">Top 2 Energy Stocks That May Implode This Quarter</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48530507\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Coinbase-Logo-Displayed-On-A-Smartphone-.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48530507/coinbase-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2",
            "pub_date": "2025-10-30 22:33:49",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690378acecb8a70001458e47",
            "title": "TotalEnergies Mixed Q3: Weak LNG Earnings Offset by Refining Strength",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>TotalEnergies SE </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TTE\" target=\"_blank\">TTE</a>) shares are trading lower on Thursday after the company reported third-quarter 2025 earnings <a href=\"https://www.benzinga.com/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">that missed street estimates</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Details</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The French energy giant posted adjusted earnings <a href=\"https://totalenergies.com/system/files/documents/totalenergies_pr-results-3q25_2025_en.pdf\" rel=\"noreferrer noopener\" target=\"_blank\">of </a>$1.77 per share, missing the $1.81 consensus estimate.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue for the quarter came in at $48.69 billion, also below expectations of $54.93 billion.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: </em></strong><em><a href=\"https://www.benzinga.com/markets/large-cap/25/10/48455357/totalenergies-wins-big-in-saudi-arabia-with-400-mw-solar-power-deal\" rel=\"noreferrer noopener\" target=\"_blank\">TotalEnergies Wins Big In Saudi Arabia With 400 MW Solar Power Deal</a></em></p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">Adjusted net income was $3.98 billion, up 11% from the prior quarter. Adjusted EBITDA totaled $10.3 billion, up 6% quarter-over-quarter (Q/Q).</p><!--/$--><!--$--><p class=\"block core-block\">Cash flow from operations excluding working capital changes stood at $7.1 billion in the quarter.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Exploration &amp; Production generated $2.17 billion in adjusted operating income, a 10% sequential decline.</li>\n<li>Integrated LNG earnings fell 18% Q/Q to $852 million, due to the planned turnaround at Ichthys LNG in Australia.</li>\n<li>Integrated Power posted a 1% Q/Q increase in income to $571 million.</li>\n<li>Refining &amp; Chemicals saw income climb 77% Q/Q to $687 million, while Marketing &amp; Services fell 8% Q/Q to $380 million.</li>\n</ul><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Production Update</h2><!--/$--><!--$--><p class=\"block core-block\">TotalEnergies reported hydrocarbon production of 2.51 million barrels of oil equivalent per day, broadly flat year-over-year, driven by project ramp-ups in the United States, Argentina and Denmark.</p><!--/$--><!--$--><p class=\"block core-block\">Net Power Production rose 9% sequentially to 12.6 terawatt hours, with gross installed renewable capacity reaching 32.3 gigawatts, a 7% sequential increase.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Share Repurchase &amp; Dividend</h2><!--/$--><!--$--><p class=\"block core-block\">The company reaffirmed its commitment to shareholder returns, declaring a third interim dividend <a href=\"https://totalenergies.com/news/press-releases/totalenergies-confirms-third-interim-dividend-eu085share-fiscal-year-2025\" rel=\"noreferrer noopener\" target=\"_blank\">of</a> 0.85 euros per share, up 7.6% from the prior year.</p><!--/$--><!--$--><p class=\"block core-block\">It also repurchased $2.3 billion in shares during the quarter.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Outlook</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The company noted that oil prices are going down due to higher supply, driven by increased output from non-OPEC producers and OPEC+'s <a href=\"https://www.benzinga.com/calendars/guidance\" rel=\"noreferrer noopener\" target=\"_blank\">decision to ease voluntary production cuts</a>.</p><!--/$--><!--$--><p class=\"block core-block\">For the fourth quarter of the year, the company expects hydrocarbon production to grow around 4% year-over-year and remain within the 2.525-2.575 Mboe/d range.</p><!--/$--><!--$--><p class=\"block core-block\">TTE expects fourth-quarter average LNG selling prices of $8.5 per million British thermal units.</p><!--/$--><!--$--><p class=\"block core-block\">TotalEnergies reiterated full-year net investment guidance of $17 billion to $17.5 billion. The company expects proceeds from the fourth-quarter disposal to be $2 billion.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> TTE shares were trading 1.73% lower at $61.15 at the last check on Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48530687\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/news/esg/25/10/48037495/totalenergies-veolia-partner-to-drive-low-carbon-future\" rel=\"noreferrer noopener\" target=\"_blank\">TotalEnergies, Veolia Partner To Drive Low-Carbon Future</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/TotalEnergies--Inx.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48530687/totalenergies-mixed-q3-weak-lng-earnings-offset-by-refining-strength",
            "pub_date": "2025-10-30 22:39:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69038127ecb8a70001459477",
            "title": "If You Invested $1000 In nVent Electric Stock 5 Years Ago, You Would Have This Much Today",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">nVent Electric (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVT\" target=\"_blank\">NVT</a>) has outperformed the market over the past 5 years by 25.48% on an annualized basis producing an average annual return of 40.77%. Currently, nVent Electric has a market capitalization of $17.51 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In NVT:</strong> If an investor had bought $1000 of NVT stock 5 years ago, it would be worth <strong>$5,682.35</strong> today based on a price of $106.26 for NVT at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">nVent Electric's Performance Over Last 5 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761837352_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761837352_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761837352_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48532400/if-you-invested-1000-in-nvent-electric-stock-5-years-ago-you-would-have-this-much-today",
            "pub_date": "2025-10-30 23:15:56",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}